Table 4

Comparison of M-protein level by sex, age at diagnosis, and exposure status

MP < 1.5 g/dLMP ≥ 1.5 g/dLP*
Total, no. (%) 378 (48.4) 403 (51.6)  
Sex, no. (%)    
    Male 195 (50.7) 190 (49.4) .21 
    Female 183 (46.2) 110 (27.8)  
Age at exposure, no. (%)    
    0-9 y 83 (51.2) 79 (48.8) .004 
    10-19 y 183 (53.2) 161 (46.8)  
    20-29 y 78 (42.9) 104 (57.1)  
    ≥ 30 y 34 (36.6) 59 (63.4)  
Age at diagnosis, no. (%)    
    < 50 y 7 (35.0) 13 (65.0) .93 
    50-59 y 68 (50.8) 66 (49.2)  
    60-69 y 141 (47.8) 154 (52.2)  
    70-79 y 125 (50.8) 121 (49.2)  
    ≥ 80 y 37 (43.0) 49 (57.0)  
Exposure distance, no. (%)    
    < 1.5 km 34 (52.3) 31 (47.7) .25 
    1.5-3.0 km 79 (40.5) 116 (59.5)  
    ≥ 3.0 km 265 (50.9) 256 (49.1)  
Exposure dose, no. (%)    
    > 0.1 Gy 9 (34.6) 17 (65.4) .92 
    0.01-0.1 Gy 10 (29.4) 24 (70.6)  
    0-0.01 Gy 11 (35.5) 20 (64.5)  
MP < 1.5 g/dLMP ≥ 1.5 g/dLP*
Total, no. (%) 378 (48.4) 403 (51.6)  
Sex, no. (%)    
    Male 195 (50.7) 190 (49.4) .21 
    Female 183 (46.2) 110 (27.8)  
Age at exposure, no. (%)    
    0-9 y 83 (51.2) 79 (48.8) .004 
    10-19 y 183 (53.2) 161 (46.8)  
    20-29 y 78 (42.9) 104 (57.1)  
    ≥ 30 y 34 (36.6) 59 (63.4)  
Age at diagnosis, no. (%)    
    < 50 y 7 (35.0) 13 (65.0) .93 
    50-59 y 68 (50.8) 66 (49.2)  
    60-69 y 141 (47.8) 154 (52.2)  
    70-79 y 125 (50.8) 121 (49.2)  
    ≥ 80 y 37 (43.0) 49 (57.0)  
Exposure distance, no. (%)    
    < 1.5 km 34 (52.3) 31 (47.7) .25 
    1.5-3.0 km 79 (40.5) 116 (59.5)  
    ≥ 3.0 km 265 (50.9) 256 (49.1)  
Exposure dose, no. (%)    
    > 0.1 Gy 9 (34.6) 17 (65.4) .92 
    0.01-0.1 Gy 10 (29.4) 24 (70.6)  
    0-0.01 Gy 11 (35.5) 20 (64.5)  

Data were used for only patients with MGUS with a heavy-chain class of A, G, and M and with available information on exposure distance and exposure dose. MP indicates M-protein concentration.

*

P values were calculated using the χ2 test or the Fisher exact test.

Close Modal

or Create an Account

Close Modal
Close Modal